-
1.
公开(公告)号:US20080299194A1
公开(公告)日:2008-12-04
申请号:US12158236
申请日:2006-12-11
CPC分类号: A61K9/0056 , A61K9/2018
摘要: A pharmaceutical formulation in the form of agglomerates comprising a) 60-97% by weight of sugar or sugar alcohols, b) 1-25% by weight of crosslinked polyvinylpyrrolidone, c) 1-15% by weight of water-insoluble, film-forming polymers, d) 0-15% by weight of water-soluble polymers and e) 0-15% by weight of further pharmaceutically customary excipients, the sum of the components a) to e) being 100% by weight.
摘要翻译: 附聚物形式的药物制剂,其包含a)60-97重量%的糖或糖醇,b)1-25重量%的交联聚乙烯吡咯烷酮,c)1-15重量%的不溶于水的, 形成聚合物,d)0-15重量%的水溶性聚合物和e)0-15重量%的其它药学上常规的赋形剂,组分a)至e)的总和为100重量%。
-
2.
公开(公告)号:US08425935B2
公开(公告)日:2013-04-23
申请号:US12158236
申请日:2006-12-11
CPC分类号: A61K9/0056 , A61K9/2018
摘要: A pharmaceutical formulation in the form of agglomerates comprising a) 60-97% by weight of sugar or sugar alcohols, b) 1-25% by weight of crosslinked polyvinylpyrrolidone, c) 1-15% by weight of water-insoluble, film-forming polymers, d) 0-15% by weight of water-soluble polymers and e) 0-15% by weight of further pharmaceutically customary excipients, the sum of the components a) to e) being 100% by weight.
摘要翻译: 附聚物形式的药物制剂,其包含a)60-97重量%的糖或糖醇,b)1-25重量%的交联聚乙烯吡咯烷酮,c)1-15重量%的不溶于水的, 形成聚合物,d)0-15重量%的水溶性聚合物和e)0-15重量%的其它药学上常规的赋形剂,组分a)至e)的总和为100重量%。
-